Journal ArticleOPEN ACCESS

CYP2B6 18492T→C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype *1/*1

Antimicrobial Agents and Chemotherapy (2014) 58(4) 2268-2273
DOI: 10.1128/AAC.02384-13
14Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

40 copies/ml and developed efavirenz-associated mutations (P = 0.254). In summary, the CYP2B6 18492T→C polymorphism compromises efavirenz concentrations in patients who carry CYP2B6 haplotype *1/*1 and are coinfected with HIV and tuberculosis. Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Manosuthi, W., Sukasem, C., Thongyen, S., Nilkamhang, S., Manosuthi, S., & Sungkanuparph, S. (2014). CYP2B6 18492T→C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype *1/*1. Antimicrobial Agents and Chemotherapy, 58(4), 2268–2273. https://doi.org/10.1128/AAC.02384-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free